Epigenetic pro fi ling for the molecular classi fi cation of metastatic brain tumors

[1]  George C Tseng,et al.  Transcriptome Characterization of Matched Primary Breast and Brain Metastatic Tumors to Detect Novel Actionable Targets , 2018, Journal of the National Cancer Institute.

[2]  Richard A Scolyer,et al.  Brain metastasis DNA methylomes, a novel resource for the identification of biological and clinical features , 2018, Scientific Data.

[3]  A. Mariani,et al.  Current landscape and future perspective of sentinel node mapping in endometrial cancer , 2018, Journal of gynecologic oncology.

[4]  Till Acker,et al.  DNA methylation-based classification of central nervous system tumours , 2018, Nature.

[5]  Eudocia Q Lee,et al.  Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study , 2017, Neuro-oncology.

[6]  Y. Marie,et al.  Same-day genomic and epigenomic diagnosis of brain tumors using real-time nanopore sequencing , 2017, Acta Neuropathologica.

[7]  B. Taylor,et al.  Implementing Genome-Driven Oncology , 2017, Cell.

[8]  Peter W. Laird,et al.  Comprehensive characterization, annotation and innovative use of Infinium DNA methylation BeadChip probes , 2016, Nucleic acids research.

[9]  W. Gradishar,et al.  Developmental therapeutics for patients with breast cancer and central nervous system metastasis: current landscape and future perspectives. , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[10]  M. Chamberlain,et al.  Systemic therapy of brain metastases: non-small cell lung cancer, breast cancer, and melanoma. , 2017, Neuro-oncology.

[11]  A. Tutt,et al.  3rd ESO-ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3). , 2017, Breast.

[12]  P. Bult,et al.  Discrepancies between biomarkers of primary breast cancer and subsequent brain metastases: an international multicenter study , 2017, Breast Cancer Research and Treatment.

[13]  Martin Sill,et al.  Radiogenomics of Glioblastoma: Machine Learning-based Classification of Molecular Characteristics by Using Multiparametric and Multiregional MR Imaging Features. , 2016, Radiology.

[14]  J. Hainfellner,et al.  Descriptive statistical analysis of a real life cohort of 2419 patients with brain metastases of solid cancers , 2016, ESMO Open.

[15]  R. Jenkins,et al.  Changing molecular profile of brain metastases compared with matched breast primary cancers and impact on clinical outcomes , 2016, British Journal of Cancer.

[16]  Steven J. M. Jones,et al.  Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma , 2016, Cell.

[17]  Gianluca Bontempi,et al.  TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data , 2015, Nucleic acids research.

[18]  M. Esteller,et al.  Validation of a DNA methylation microarray for 850,000 CpG sites of the human genome enriched in enhancer sequences , 2015, Epigenomics.

[19]  É. Emery,et al.  Histopathologic diagnosis of brain metastases: current trends in management and future considerations , 2016, Brain Tumor Pathology.

[20]  A. Butte,et al.  Systematic pan-cancer analysis of tumour purity , 2015, Nature Communications.

[21]  Robert T. Jones,et al.  Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets. , 2015, Cancer discovery.

[22]  K. Nael,et al.  Differentiation of solitary brain metastasis from glioblastoma multiforme: a predictive multiparametric approach using combined MR diffusion and perfusion , 2015, Neuroradiology.

[23]  D. Morton,et al.  Brain metastasis is predetermined in early stages of cutaneous melanoma by CD44v6 expression through epigenetic regulation of the spliceosome , 2015, Pigment cell & melanoma research.

[24]  M. Edson,et al.  Recommendations on Disease Management for Patients With Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer and Brain Metastases: American Society of Clinical Oncology Clinical Practice Guideline , 2015 .

[25]  Yusuke Ishida,et al.  Brain metastasis: clinical characteristics, pathological findings and molecular subtyping for therapeutic implications , 2015, Brain Tumor Pathology.

[26]  J. Wilmott,et al.  DNA methylation and gene deletion analysis of brain metastases in melanoma patients identifies mutually exclusive molecular alterations. , 2014, Neuro-oncology.

[27]  Benjamin J. Raphael,et al.  Multiplatform Analysis of 12 Cancer Types Reveals Molecular Classification within and across Tissues of Origin , 2014, Cell.

[28]  Neal P. Kawas,et al.  Multi-platform genome-wide analysis of melanoma progression to brain metastasis , 2014, Genomics data.

[29]  M. Kris,et al.  Serpins Promote Cancer Cell Survival and Vascular Co-Option in Brain Metastasis , 2014, Cell.

[30]  John M S Bartlett,et al.  Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. , 2014, Archives of pathology & laboratory medicine.

[31]  G. Gandaglia,et al.  Epidemiology and Pathophysiology of LUTS/BPO , 2014 .

[32]  Neal P. Kawas,et al.  Epigenome-wide DNA methylation landscape of melanoma progression to brain metastasis reveals aberrations on homeobox D cluster associated with prognosis. , 2014, Human molecular genetics.

[33]  Laurens van der Maaten,et al.  Accelerating t-SNE using tree-based algorithms , 2014, J. Mach. Learn. Res..

[34]  M. J. van den Bent,et al.  MGMT-STP27 Methylation Status as Predictive Marker for Response to PCV in Anaplastic Oligodendrogliomas and Oligoastrocytomas. A Report from EORTC Study 26951 , 2013, Clinical Cancer Research.

[35]  A. Perry,et al.  Neuropathology of brain metastases , 2013, Surgical neurology international.

[36]  R. Weksberg,et al.  Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray , 2013, Epigenetics.

[37]  A. Oshlack,et al.  SWAN: Subset-quantile Within Array Normalization for Illumina Infinium HumanMethylation450 BeadChips , 2012, Genome Biology.

[38]  A. Erdreich-Epstein,et al.  Heparanase-Induced GEF-H1 Signaling Regulates the Cytoskeletal Dynamics of Brain Metastatic Breast Cancer Cells , 2012, Molecular Cancer Research.

[39]  M. Esteller,et al.  Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome , 2011, Epigenetics.

[40]  Shu Ichihara,et al.  Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists , 2011, Modern Pathology.

[41]  Anthony Rhodes,et al.  American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. , 2010, Archives of pathology & laboratory medicine.

[42]  Cory Y. McLean,et al.  GREAT improves functional interpretation of cis-regulatory regions , 2010, Nature Biotechnology.

[43]  鮫島 浩,et al.  Population-based study からみた神経予後不良因子の検討 , 2009 .

[44]  C. Perou,et al.  Mammary development meets cancer genomics , 2009, Nature Medicine.

[45]  Geoffrey E. Hinton,et al.  Visualizing Data using t-SNE , 2008 .

[46]  J. Posner,et al.  Brain metastases: epidemiology and pathophysiology. , 2007, Cancer treatment and research.

[47]  L. Davis,et al.  Immunohistochemical Analysis of Metastatic Neoplasms of the Central Nervous System , 2006, Journal of neuropathology and experimental neurology.

[48]  W. Liang,et al.  TM4 microarray software suite. , 2006, Methods in enzymology.

[49]  J. Washington,et al.  An international multicenter study of blood culture practices , 1992, European Journal of Clinical Microbiology and Infectious Diseases.

[50]  Jill S Barnholtz-Sloan,et al.  Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[51]  L. Deangelis,et al.  Treatment of brain metastases. , 2004, The journal of supportive oncology.

[52]  A. Twijnstra,et al.  Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma , 2002, Cancer.